89 related articles for article (PubMed ID: 2948607)
1. Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.
Thomas EJ; Jenkins J; Lenton EA; Cooke ID
Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407-8. PubMed ID: 2948607
[No Abstract] [Full Text] [Related]
2. The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
Williams MR; Walker KJ; Turkes A; Blamey RW; Nicholson RI
Br J Cancer; 1986 May; 53(5):629-36. PubMed ID: 2941044
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system.
Williams G; Kerle D; Griffin S; Dunlop H; Bloom SR
Br Med J (Clin Res Ed); 1984 Dec; 289(6458):1580-1. PubMed ID: 6239674
[No Abstract] [Full Text] [Related]
4. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
Costantini S; Anserini P; Valenzano M; Remorgida V; Venturini PL; De Cecco L
Eur J Obstet Gynecol Reprod Biol; 1990 Oct; 37(1):63-9. PubMed ID: 2142921
[TBL] [Abstract][Full Text] [Related]
5. Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women.
Matta WH; Shaw RW; Burford GD
Fertil Steril; 1988 Jan; 49(1):163-5. PubMed ID: 2961621
[TBL] [Abstract][Full Text] [Related]
6. Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex.
Holdaway IM; Parr CE; France J
Aust N Z J Obstet Gynaecol; 1991 May; 31(2):164-5. PubMed ID: 1834050
[TBL] [Abstract][Full Text] [Related]
7. Goserelin depot in the treatment of premenopausal advanced breast cancer.
Blamey RW; Jonat W; Kaufmann M; Bianco AR; Namer M
Eur J Cancer; 1992; 28A(4-5):810-4. PubMed ID: 1388037
[TBL] [Abstract][Full Text] [Related]
8. Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer.
Walker KJ; Walker RF; Turkes A; Robertson JF; Blamey RW; Griffiths K; Nicholson RI
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):651-4. PubMed ID: 2523808
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)--lack of shrinkage of uterine fibroids.
Lumsden MA; West CP; Hillier H; Baird DT
Fertil Steril; 1989 Dec; 52(6):924-9. PubMed ID: 2531684
[TBL] [Abstract][Full Text] [Related]
10. Treatment of pre-menopausal advanced breast cancer with goserelin--a long-acting luteinizing hormone releasing hormone agonist.
Brambilla C; Escobedo A; Artioli R; Lechuga MJ; Motta M
Anticancer Drugs; 1992 Feb; 3(1):3-8. PubMed ID: 1535804
[TBL] [Abstract][Full Text] [Related]
11. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H
Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149
[TBL] [Abstract][Full Text] [Related]
12. An LH-RH analogue (Zoladex) in the management of carcinoma of the prostate: a preliminary report comparing daily subcutaneous injections with monthly depot injections.
Robinson MR; Denis L; Mahler C; Walker K; Stitch R; Lunglmayr G
Eur J Surg Oncol; 1985 Jun; 11(2):159-65. PubMed ID: 3159598
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women.
Filicori M; Flamigni C; Cognigni G; Dellai P; Arnone R; Falbo A; Capelli M
J Clin Endocrinol Metab; 1993 Jul; 77(1):130-3. PubMed ID: 8325935
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
Lukkarinen O; Kontturi M
Scand J Urol Nephrol Suppl; 1988; 110():109-12. PubMed ID: 2973121
[TBL] [Abstract][Full Text] [Related]
15. [Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer].
Schmid H; Schachner-Wünschmann E; Kaufmann M
Arch Gynecol Obstet; 1989; 245(1-4):741-3. PubMed ID: 2529825
[No Abstract] [Full Text] [Related]
16. Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer.
Walker KJ; Turkes A; Williams MR; Blamey RW; Nicholson RI
J Endocrinol; 1986 Nov; 111(2):349-53. PubMed ID: 2947964
[TBL] [Abstract][Full Text] [Related]
17. Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.
Kaufmann M; Jonat W; Kleeberg U; Eiermann W; Jänicke F; Hilfrich J; Kreienberg R; Albrecht M; Weitzel HK; Schmid H
J Clin Oncol; 1989 Aug; 7(8):1113-9. PubMed ID: 2526863
[TBL] [Abstract][Full Text] [Related]
18. Long term therapy with a depot LHRH analogue (Zoladex) in patients with advanced prostatic cancer.
Denis L; Keuppens F; Mahler C; Debruyne FM; Weil EH; Lunglmayr G; Newling D; Robinson MR; Richards B; Smith PH
Prog Clin Biol Res; 1987; 243A():221-7. PubMed ID: 2958852
[No Abstract] [Full Text] [Related]
19. Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results.
Venturini PL; Fasce V; Costantini S; Anserini P; Cucuccio S; de Cecco L
Fertil Steril; 1990 Dec; 54(6):1021-7. PubMed ID: 2147154
[TBL] [Abstract][Full Text] [Related]
20. Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomata uteri.
Candiani GB; Vercellini P; Fedele L; Arcaini L; Bianchi S; Candiani M
Acta Obstet Gynecol Scand; 1990; 69(5):413-5. PubMed ID: 2148663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
